<Suppliers Price>

KB3022

Names

[ CAS No. ]:
101001-34-7

[ Name ]:
KB3022

[Synonym ]:
KB-3022
Ethyl 2-(4,5-bis(4-methoxyphenyl)-2-thiazolyl)-1H-pyrrole-1-acetate
Pamicogrel
KBT-3022
1H-Pyrrole-1-acetic acid,2-(4,5-bis(4-methoxyphenyl)-2-thiazolyl)-,ethyl ester
Ethyl 2-(4,5-bis(p-methoxyphenyl)-2-thiazolyl)pyrrole-1-acetate
ethyl 2-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]-pyrrole-1-acetate
ethyl 2-<4,5-bis(4-methoxyphenyl)thiazole-2-yl>pyrrol-1-yl acetate
KB3022

Biological Activity

[Description]:

KB3022 is a cyclooxygenase (COX) inhibitor.

[Related Catalog]:

Research Areas >> Cardiovascular Disease

[Target]

Cyclooxygenase


[In Vitro]

KB3022 (Pamicogrel) is a cyclooxygenase inhibitor with platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. KB3022 also has potential in both prophylaxis and treatment of ischemic brain injury[1].

[References]

[1]. Light P. Pamicogrel (Kanebo). IDrugs. 1999 Sep;2(9):938-42.


[Related Small Molecules]

4-Acetamidophenol | Aspirin | Paradol | Ginsenoside Rg3 | Ginsenoside Compound K | Xanthohumol | Ibuprofen | Diclofenac | NS-398 | Meloxicam | Flufenamic Acid | Epicatechin | Salicylic acid | ketoprofen | Naproxen

Chemical & Physical Properties

[ Density]:
1.22g/cm3

[ Boiling Point ]:
600.3ºC at 760mmHg

[ Molecular Formula ]:
C25H24N2O4S

[ Molecular Weight ]:
448.53400

[ Flash Point ]:
316.8ºC

[ Exact Mass ]:
448.14600

[ PSA ]:
90.82000

[ LogP ]:
5.52590

[ Vapour Pressure ]:
2.28E-14mmHg at 25°C

[ Index of Refraction ]:
1.612

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UX9276399
CHEMICAL NAME :
1H-Pyrrole-1-acetic acid, 2-(4,5-bis(4-methoxyphenyl)-2-thiazolyl)-, ethyl ester
CAS REGISTRY NUMBER :
101001-34-7
LAST UPDATED :
199606
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C25-H24-N2-O4-S
MOLECULAR WEIGHT :
448.57

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4659726

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.